 Microbial Sensitivity Tests
"Microbial Sensitivity Tests" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses).
| Descriptor ID |
D008826
|
| MeSH Number(s) |
E01.370.225.875.595 E05.200.875.595 E05.337.550.400
|
| Concept/Terms |
Microbial Sensitivity Tests- Microbial Sensitivity Tests
- Microbial Sensitivity Test
- Sensitivity Test, Microbial
- Sensitivity Tests, Microbial
- Test, Microbial Sensitivity
- Tests, Microbial Sensitivity
- Drug Sensitivity Assay, Microbial
Minimum Inhibitory Concentration- Minimum Inhibitory Concentration
- Concentration, Minimum Inhibitory
- Concentrations, Minimum Inhibitory
- Inhibitory Concentration, Minimum
- Inhibitory Concentrations, Minimum
- Minimum Inhibitory Concentrations
Bacterial Sensitivity Tests- Bacterial Sensitivity Tests
- Tests, Bacterial Sensitivity
- Sensitivity Tests, Bacterial
- Test, Bacterial Sensitivity
- Bacterial Sensitivity Test
- Sensitivity Test, Bacterial
|
Below are MeSH descriptors whose meaning is more general than "Microbial Sensitivity Tests".
Below are MeSH descriptors whose meaning is more specific than "Microbial Sensitivity Tests".
This graph shows the total number of publications written about "Microbial Sensitivity Tests" by people in this website by year, and whether "Microbial Sensitivity Tests" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 3 | 3 | | 1998 | 0 | 1 | 1 | | 1999 | 1 | 1 | 2 | | 2001 | 0 | 3 | 3 | | 2002 | 0 | 2 | 2 | | 2003 | 0 | 6 | 6 | | 2004 | 1 | 8 | 9 | | 2005 | 0 | 4 | 4 | | 2006 | 0 | 3 | 3 | | 2007 | 0 | 6 | 6 | | 2008 | 0 | 9 | 9 | | 2009 | 0 | 7 | 7 | | 2010 | 0 | 9 | 9 | | 2011 | 0 | 15 | 15 | | 2012 | 1 | 18 | 19 | | 2013 | 0 | 11 | 11 | | 2014 | 1 | 10 | 11 | | 2015 | 1 | 7 | 8 | | 2016 | 1 | 14 | 15 | | 2017 | 0 | 15 | 15 | | 2018 | 2 | 10 | 12 | | 2019 | 3 | 14 | 17 | | 2020 | 1 | 12 | 13 | | 2021 | 1 | 18 | 19 | | 2022 | 0 | 10 | 10 | | 2023 | 0 | 9 | 9 | | 2024 | 6 | 9 | 15 | | 2025 | 0 | 14 | 14 | | 2026 | 0 | 7 | 7 |
To return to the timeline, click here.
Below are the most recent publications written about "Microbial Sensitivity Tests" by people in Profiles.
-
Logan N, Birhane MG, McDonald SL, Alarcón J, Amador S, Anand M, Bachmann LH, Bernard K, Black LS, Chen AN, Cooley LA, Fortes ED, Gerard M, Jervis RH, Kimura AC, Lamba K, Latash J, Li L, Pederson G, Kauffman CP, Reynolds JL, Santiago R, Siemetzki-Kapoor U, Smole SC, Tagg KA, Vostok J, Webb HE, Francois Watkins LK. Emergence of Extensively Drug-Resistant Shigellosis - United States, 2011-2023. MMWR Morb Mortal Wkly Rep. 2026 Apr 09; 75(13):173-178.
-
Poonawala H, Davis K, Kenny ME, Alivisatos A, Van N, Washington T, Calado Nogueira de Moura V, Daley CL, Aldridge BB. Antibiotic dose-response curves can measure antibiotic activity against Mycobacterium abscessus and Mycobacterium peregrinum. Antimicrob Agents Chemother. 2026 May 06; 70(5):e0187625.
-
Kim JS, Kumar V, Liu L, Choi YJ, Senovaityte S, McCollister BD, Wlodarchak N, Orlicky DJ, Rice PJ, Dai S, Wempe MF, Vázquez-Torres A. DksA inhibitors against intracellular and persistent Salmonella are effective in acute models of infection. Sci Adv. 2026 Mar 20; 12(12):eaea6832.
-
Pham TH, Molina KC, Huang V. Predicting oral cephalosporin susceptibility in Escherichia coli blood isolates using parenteral cephalosporin susceptibility testing. J Antimicrob Chemother. 2026 Mar 04; 81(4).
-
Riedel C, Rahkola J, Reichlen M, Ries H, Ericksen SS, Voskuil M, Gitter A, Wlodarchak N. Identification and characterization of inhibitors of the tuberculosis phosphatase PstP. J Biol Chem. 2026 Apr; 302(4):111316.
-
Dousa KM, Shin E, Kurz SG, Rubin EJ, Holland SM, Olivier KN, Daley CL, Kreiswirth BN, Pottinger PS, Bonomo RA. The Role of ß-Lactam Antibiotics in Treating Mycobacterium abscessus: From Laboratory Insights to Clinical Applications and the Case for Clinical Trials. Clin Infect Dis. 2026 Feb 09; 82(1):e135-e145.
-
Singh S, Boorgula GD, Nguyen MH, Daley CL, Gumbo T, Srivastava S. Preclinical evaluation of epetraborole in the hollow fibre system model of Mycobacterium abscessus lung disease. J Antimicrob Chemother. 2026 Jan 06; 81(1).
-
Asamoto CK, Ewing CA, Meyer CT, Allgood SC, Eldridge MJG, Evans D, Nagy TA, Christensen GL, Crooks AL, Jiang D, Helaine S, Detweiler CS. A two-step screen identifies a small molecule that disrupts membrane voltage and is effective against growing and persister gram-negative bacteria. Microbiol Spectr. 2026 Feb 03; 14(2):e0321725.
-
Nguyen MH, Plattner M, Verma D, Krishnamurthy RV, Xie M, Calado Nogueira de Moura V, Haldimann K, Lang R, Becker K, Kaur P, Shandil RK, Singh M, Bulman ZP, Dick T, Narayanan S, Schulthess B, Mitarai S, Daley CL, Hobbie SN. Multicentre preclinical profiling of apramycin for the treatment of nontuberculous mycobacteria. EBioMedicine. 2026 Jan; 123:106103.
-
Nguyen A, Bunch ZL, Martinez-Aldino IY, Rangel-Grimaldo M, Tak U, Thorstenson JC, Severn MM, Nakatsuji T, Gallo RL, Graf TN, Oberlies NH, Chekan JR, Cech NB, Horswill AR. An antimicrobial daptide from human skin commensal Staphylococcus hominis protects against skin pathogens. Nat Commun. 2025 Dec 11; 16(1):11459.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|